 | • レポートコード：MRC2-11QY12658 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はメタボロミクスバイオマーカーのグローバル市場について調査・分析したレポートです。種類別（ガスクロマトグラフィー、高速液体クロマトグラフィー、超高速液体クロマトグラフィー、核磁気共鳴、質量分析、表面ベース質量分析、バイオインフォマティクス）市場規模、用途別（毒物学的研究、薬物検査、癌、心血管障害、神経障害、先天性代謝異常症）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別メタボロミクスバイオマーカーの競争状況、市場シェア ・世界のメタボロミクスバイオマーカー市場：種類別市場規模 2015年-2020年（ガスクロマトグラフィー、高速液体クロマトグラフィー、超高速液体クロマトグラフィー、核磁気共鳴、質量分析、表面ベース質量分析、バイオインフォマティクス） ・世界のメタボロミクスバイオマーカー市場：種類別市場規模予測 2021年-2026年（ガスクロマトグラフィー、高速液体クロマトグラフィー、超高速液体クロマトグラフィー、核磁気共鳴、質量分析、表面ベース質量分析、バイオインフォマティクス） ・世界のメタボロミクスバイオマーカー市場：用途別市場規模 2015年-2020年（毒物学的研究、薬物検査、癌、心血管障害、神経障害、先天性代謝異常症） ・世界のメタボロミクスバイオマーカー市場：用途別市場規模予測 2021年-2026年（毒物学的研究、薬物検査、癌、心血管障害、神経障害、先天性代謝異常症） ・北米のメタボロミクスバイオマーカー市場分析：米国、カナダ ・ヨーロッパのメタボロミクスバイオマーカー市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのメタボロミクスバイオマーカー市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のメタボロミクスバイオマーカー市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのメタボロミクスバイオマーカー市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Biocrates Life Sciences、Biomark Diagnostics、Chenomx、Creative Proteomics、Evotec、Human Metabolome Technologies、Merck、Metabolomic Diagnostics、Metabolon、Ovid Therapeutics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Metabolomics is referred as the large-scale study of small molecules, commonly known as metabolites, within tissues, cells, biofluids or organisms.
Innovative development in informatics and analytical technologies and increasing pharmaceutical and biotech R&D expenditure are expected to significantly contribute in the market growth during forecast period. Other factors such as ongoing research on metabolomics biomarker and extensive application of metabolomics biomarker such as in colorectal cancer detection are also expected to drive the market growth. Further, increasing pharmaceutical and biotech R&D expenditure is also contributing in the market.
Market Analysis and Insights: Global Metabolomics Biomarker Market
The global Metabolomics Biomarker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Metabolomics Biomarker Scope and Market Size
Metabolomics Biomarker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Metabolomics Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Biocrates Life Sciences
Biomark Diagnostics
Chenomx
Creative Proteomics
Evotec
Human Metabolome Technologies
Merck
Metabolomic Diagnostics
Metabolon
Ovid Therapeutics
Market segment by Type, the product can be split into
Gas chromatography
High-performance liquid chromatography
Ultra-performance liquid chromatography
Nuclear magnetic resonance
Mass spectrometry
Surface-based mass analysis
Bioinformatics
Market segment by Application, split into
Toxicological studies
Drug testing
Cancer
Cardiovascular disorders
Neurological disorders
Inborn errors of metabolism
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Metabolomics Biomarker Revenue
1.4 Market by Type
1.4.1 Global Metabolomics Biomarker Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Gas chromatography
1.4.3 High-performance liquid chromatography
1.4.4 Ultra-performance liquid chromatography
1.4.5 Nuclear magnetic resonance
1.4.6 Mass spectrometry
1.4.7 Surface-based mass analysis
1.4.8 Bioinformatics
1.5 Market by Application
1.5.1 Global Metabolomics Biomarker Market Share by Application: 2020 VS 2026
1.5.2 Toxicological studies
1.5.3 Drug testing
1.5.4 Cancer
1.5.5 Cardiovascular disorders
1.5.6 Neurological disorders
1.5.7 Inborn errors of metabolism
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Metabolomics Biomarker Market Perspective (2015-2026)
2.2 Global Metabolomics Biomarker Growth Trends by Regions
2.2.1 Metabolomics Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Metabolomics Biomarker Historic Market Share by Regions (2015-2020)
2.2.3 Metabolomics Biomarker Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Metabolomics Biomarker Market Growth Strategy
2.3.6 Primary Interviews with Key Metabolomics Biomarker Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Metabolomics Biomarker Players by Market Size
3.1.1 Global Top Metabolomics Biomarker Players by Revenue (2015-2020)
3.1.2 Global Metabolomics Biomarker Revenue Market Share by Players (2015-2020)
3.1.3 Global Metabolomics Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Metabolomics Biomarker Market Concentration Ratio
3.2.1 Global Metabolomics Biomarker Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Metabolomics Biomarker Revenue in 2019
3.3 Metabolomics Biomarker Key Players Head office and Area Served
3.4 Key Players Metabolomics Biomarker Product Solution and Service
3.5 Date of Enter into Metabolomics Biomarker Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Metabolomics Biomarker Historic Market Size by Type (2015-2020)
4.2 Global Metabolomics Biomarker Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Metabolomics Biomarker Market Size by Application (2015-2020)
5.2 Global Metabolomics Biomarker Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Metabolomics Biomarker Market Size (2015-2020)
6.2 Metabolomics Biomarker Key Players in North America (2019-2020)
6.3 North America Metabolomics Biomarker Market Size by Type (2015-2020)
6.4 North America Metabolomics Biomarker Market Size by Application (2015-2020)
7 Europe
7.1 Europe Metabolomics Biomarker Market Size (2015-2020)
7.2 Metabolomics Biomarker Key Players in Europe (2019-2020)
7.3 Europe Metabolomics Biomarker Market Size by Type (2015-2020)
7.4 Europe Metabolomics Biomarker Market Size by Application (2015-2020)
8 China
8.1 China Metabolomics Biomarker Market Size (2015-2020)
8.2 Metabolomics Biomarker Key Players in China (2019-2020)
8.3 China Metabolomics Biomarker Market Size by Type (2015-2020)
8.4 China Metabolomics Biomarker Market Size by Application (2015-2020)
9 Japan
9.1 Japan Metabolomics Biomarker Market Size (2015-2020)
9.2 Metabolomics Biomarker Key Players in Japan (2019-2020)
9.3 Japan Metabolomics Biomarker Market Size by Type (2015-2020)
9.4 Japan Metabolomics Biomarker Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Metabolomics Biomarker Market Size (2015-2020)
10.2 Metabolomics Biomarker Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Metabolomics Biomarker Market Size by Type (2015-2020)
10.4 Southeast Asia Metabolomics Biomarker Market Size by Application (2015-2020)
11 India
11.1 India Metabolomics Biomarker Market Size (2015-2020)
11.2 Metabolomics Biomarker Key Players in India (2019-2020)
11.3 India Metabolomics Biomarker Market Size by Type (2015-2020)
11.4 India Metabolomics Biomarker Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Metabolomics Biomarker Market Size (2015-2020)
12.2 Metabolomics Biomarker Key Players in Central & South America (2019-2020)
12.3 Central & South America Metabolomics Biomarker Market Size by Type (2015-2020)
12.4 Central & South America Metabolomics Biomarker Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Biocrates Life Sciences
13.1.1 Biocrates Life Sciences Company Details
13.1.2 Biocrates Life Sciences Business Overview
13.1.3 Biocrates Life Sciences Metabolomics Biomarker Introduction
13.1.4 Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2015-2020))
13.1.5 Biocrates Life Sciences Recent Development
13.2 Biomark Diagnostics
13.2.1 Biomark Diagnostics Company Details
13.2.2 Biomark Diagnostics Business Overview
13.2.3 Biomark Diagnostics Metabolomics Biomarker Introduction
13.2.4 Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2015-2020)
13.2.5 Biomark Diagnostics Recent Development
13.3 Chenomx
13.3.1 Chenomx Company Details
13.3.2 Chenomx Business Overview
13.3.3 Chenomx Metabolomics Biomarker Introduction
13.3.4 Chenomx Revenue in Metabolomics Biomarker Business (2015-2020)
13.3.5 Chenomx Recent Development
13.4 Creative Proteomics
13.4.1 Creative Proteomics Company Details
13.4.2 Creative Proteomics Business Overview
13.4.3 Creative Proteomics Metabolomics Biomarker Introduction
13.4.4 Creative Proteomics Revenue in Metabolomics Biomarker Business (2015-2020)
13.4.5 Creative Proteomics Recent Development
13.5 Evotec
13.5.1 Evotec Company Details
13.5.2 Evotec Business Overview
13.5.3 Evotec Metabolomics Biomarker Introduction
13.5.4 Evotec Revenue in Metabolomics Biomarker Business (2015-2020)
13.5.5 Evotec Recent Development
13.6 Human Metabolome Technologies
13.6.1 Human Metabolome Technologies Company Details
13.6.2 Human Metabolome Technologies Business Overview
13.6.3 Human Metabolome Technologies Metabolomics Biomarker Introduction
13.6.4 Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2015-2020)
13.6.5 Human Metabolome Technologies Recent Development
13.7 Merck
13.7.1 Merck Company Details
13.7.2 Merck Business Overview
13.7.3 Merck Metabolomics Biomarker Introduction
13.7.4 Merck Revenue in Metabolomics Biomarker Business (2015-2020)
13.7.5 Merck Recent Development
13.8 Metabolomic Diagnostics
13.8.1 Metabolomic Diagnostics Company Details
13.8.2 Metabolomic Diagnostics Business Overview
13.8.3 Metabolomic Diagnostics Metabolomics Biomarker Introduction
13.8.4 Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2015-2020)
13.8.5 Metabolomic Diagnostics Recent Development
13.9 Metabolon
13.9.1 Metabolon Company Details
13.9.2 Metabolon Business Overview
13.9.3 Metabolon Metabolomics Biomarker Introduction
13.9.4 Metabolon Revenue in Metabolomics Biomarker Business (2015-2020)
13.9.5 Metabolon Recent Development
13.10 Ovid Therapeutics
13.10.1 Ovid Therapeutics Company Details
13.10.2 Ovid Therapeutics Business Overview
13.10.3 Ovid Therapeutics Metabolomics Biomarker Introduction
13.10.4 Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2015-2020)
13.10.5 Ovid Therapeutics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Metabolomics Biomarker Key Market Segments
Table 2. Key Players Covered: Ranking by Metabolomics Biomarker Revenue
Table 3. Ranking of Global Top Metabolomics Biomarker Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Metabolomics Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Gas chromatography
Table 6. Key Players of High-performance liquid chromatography
Table 7. Key Players of Ultra-performance liquid chromatography
Table 8. Key Players of Nuclear magnetic resonance
Table 9. Key Players of Mass spectrometry
Table 10. Key Players of Surface-based mass analysis
Table 11. Key Players of Bioinformatics
Table 12. Global Metabolomics Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Metabolomics Biomarker Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Metabolomics Biomarker Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Metabolomics Biomarker Market Share by Regions (2015-2020)
Table 16. Global Metabolomics Biomarker Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Metabolomics Biomarker Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Metabolomics Biomarker Market Growth Strategy
Table 22. Main Points Interviewed from Key Metabolomics Biomarker Players
Table 23. Global Metabolomics Biomarker Revenue by Players (2015-2020) (Million US$)
Table 24. Global Metabolomics Biomarker Market Share by Players (2015-2020)
Table 25. Global Top Metabolomics Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolomics Biomarker as of 2019)
Table 26. Global Metabolomics Biomarker by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Metabolomics Biomarker Product Solution and Service
Table 29. Date of Enter into Metabolomics Biomarker Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Metabolomics Biomarker Market Size by Type (2015-2020) (Million US$)
Table 32. Global Metabolomics Biomarker Market Size Share by Type (2015-2020)
Table 33. Global Metabolomics Biomarker Revenue Market Share by Type (2021-2026)
Table 34. Global Metabolomics Biomarker Market Size Share by Application (2015-2020)
Table 35. Global Metabolomics Biomarker Market Size by Application (2015-2020) (Million US$)
Table 36. Global Metabolomics Biomarker Market Size Share by Application (2021-2026)
Table 37. North America Key Players Metabolomics Biomarker Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Metabolomics Biomarker Market Share (2019-2020)
Table 39. North America Metabolomics Biomarker Market Size by Type (2015-2020) (Million US$)
Table 40. North America Metabolomics Biomarker Market Share by Type (2015-2020)
Table 41. North America Metabolomics Biomarker Market Size by Application (2015-2020) (Million US$)
Table 42. North America Metabolomics Biomarker Market Share by Application (2015-2020)
Table 43. Europe Key Players Metabolomics Biomarker Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Metabolomics Biomarker Market Share (2019-2020)
Table 45. Europe Metabolomics Biomarker Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Metabolomics Biomarker Market Share by Type (2015-2020)
Table 47. Europe Metabolomics Biomarker Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Metabolomics Biomarker Market Share by Application (2015-2020)
Table 49. China Key Players Metabolomics Biomarker Revenue (2019-2020) (Million US$)
Table 50. China Key Players Metabolomics Biomarker Market Share (2019-2020)
Table 51. China Metabolomics Biomarker Market Size by Type (2015-2020) (Million US$)
Table 52. China Metabolomics Biomarker Market Share by Type (2015-2020)
Table 53. China Metabolomics Biomarker Market Size by Application (2015-2020) (Million US$)
Table 54. China Metabolomics Biomarker Market Share by Application (2015-2020)
Table 55. Japan Key Players Metabolomics Biomarker Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Metabolomics Biomarker Market Share (2019-2020)
Table 57. Japan Metabolomics Biomarker Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Metabolomics Biomarker Market Share by Type (2015-2020)
Table 59. Japan Metabolomics Biomarker Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Metabolomics Biomarker Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Metabolomics Biomarker Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Metabolomics Biomarker Market Share (2019-2020)
Table 63. Southeast Asia Metabolomics Biomarker Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Metabolomics Biomarker Market Share by Type (2015-2020)
Table 65. Southeast Asia Metabolomics Biomarker Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Metabolomics Biomarker Market Share by Application (2015-2020)
Table 67. India Key Players Metabolomics Biomarker Revenue (2019-2020) (Million US$)
Table 68. India Key Players Metabolomics Biomarker Market Share (2019-2020)
Table 69. India Metabolomics Biomarker Market Size by Type (2015-2020) (Million US$)
Table 70. India Metabolomics Biomarker Market Share by Type (2015-2020)
Table 71. India Metabolomics Biomarker Market Size by Application (2015-2020) (Million US$)
Table 72. India Metabolomics Biomarker Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Metabolomics Biomarker Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Metabolomics Biomarker Market Share (2019-2020)
Table 75. Central & South America Metabolomics Biomarker Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Metabolomics Biomarker Market Share by Type (2015-2020)
Table 77. Central & South America Metabolomics Biomarker Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Metabolomics Biomarker Market Share by Application (2015-2020)
Table 79. Biocrates Life Sciences Company Details
Table 80. Biocrates Life Sciences Business Overview
Table 81. Biocrates Life Sciences Product
Table 82. Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2015-2020) (Million US$)
Table 83. Biocrates Life Sciences Recent Development
Table 84. Biomark Diagnostics Company Details
Table 85. Biomark Diagnostics Business Overview
Table 86. Biomark Diagnostics Product
Table 87. Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2015-2020) (Million US$)
Table 88. Biomark Diagnostics Recent Development
Table 89. Chenomx Company Details
Table 90. Chenomx Business Overview
Table 91. Chenomx Product
Table 92. Chenomx Revenue in Metabolomics Biomarker Business (2015-2020) (Million US$)
Table 93. Chenomx Recent Development
Table 94. Creative Proteomics Company Details
Table 95. Creative Proteomics Business Overview
Table 96. Creative Proteomics Product
Table 97. Creative Proteomics Revenue in Metabolomics Biomarker Business (2015-2020) (Million US$)
Table 98. Creative Proteomics Recent Development
Table 99. Evotec Company Details
Table 100. Evotec Business Overview
Table 101. Evotec Product
Table 102. Evotec Revenue in Metabolomics Biomarker Business (2015-2020) (Million US$)
Table 103. Evotec Recent Development
Table 104. Human Metabolome Technologies Company Details
Table 105. Human Metabolome Technologies Business Overview
Table 106. Human Metabolome Technologies Product
Table 107. Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2015-2020) (Million US$)
Table 108. Human Metabolome Technologies Recent Development
Table 109. Merck Company Details
Table 110. Merck Business Overview
Table 111. Merck Product
Table 112. Merck Revenue in Metabolomics Biomarker Business (2015-2020) (Million US$)
Table 113. Merck Recent Development
Table 114. Metabolomic Diagnostics Business Overview
Table 115. Metabolomic Diagnostics Product
Table 116. Metabolomic Diagnostics Company Details
Table 117. Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2015-2020) (Million US$)
Table 118. Metabolomic Diagnostics Recent Development
Table 119. Metabolon Company Details
Table 120. Metabolon Business Overview
Table 121. Metabolon Product
Table 122. Metabolon Revenue in Metabolomics Biomarker Business (2015-2020) (Million US$)
Table 123. Metabolon Recent Development
Table 124. Ovid Therapeutics Company Details
Table 125. Ovid Therapeutics Business Overview
Table 126. Ovid Therapeutics Product
Table 127. Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2015-2020) (Million US$)
Table 128. Ovid Therapeutics Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metabolomics Biomarker Market Share by Type: 2020 VS 2026
Figure 2. Gas chromatography Features
Figure 3. High-performance liquid chromatography Features
Figure 4. Ultra-performance liquid chromatography Features
Figure 5. Nuclear magnetic resonance Features
Figure 6. Mass spectrometry Features
Figure 7. Surface-based mass analysis Features
Figure 8. Bioinformatics Features
Figure 9. Global Metabolomics Biomarker Market Share by Application: 2020 VS 2026
Figure 10. Toxicological studies Case Studies
Figure 11. Drug testing Case Studies
Figure 12. Cancer Case Studies
Figure 13. Cardiovascular disorders Case Studies
Figure 14. Neurological disorders Case Studies
Figure 15. Inborn errors of metabolism Case Studies
Figure 16. Metabolomics Biomarker Report Years Considered
Figure 17. Global Metabolomics Biomarker Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Metabolomics Biomarker Market Share by Regions: 2020 VS 2026
Figure 19. Global Metabolomics Biomarker Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Metabolomics Biomarker Market Share by Players in 2019
Figure 22. Global Top Metabolomics Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolomics Biomarker as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Metabolomics Biomarker Revenue in 2019
Figure 24. North America Metabolomics Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Metabolomics Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Metabolomics Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Metabolomics Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Metabolomics Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Metabolomics Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Metabolomics Biomarker Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed
液体クロマトグラフィー-質量分析の世界市場（～2026年） Liquid chromatography–mass spectrometry (LC-MS) is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography (or HPLC) with the mass analysis capabilities of mass spectrometry (MS). Coupled chromatography - MS systems are popular in chemical analys…- リキッドバイオプシー用循環バイオマーカーの世界市場（～2026年） Market Analysis and Insights: Global Circulating Biomarker for Liquid Biopsy Market The global Circulating Biomarker for Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Circulating Biomarker for Liquid Bi…
- キラルカラムクロマトグラフィーシステムの世界市場（～2026年） Chiral compounds are optically active and enable to rotate the polarized light to the right or to the left depending on the configuration of sample molecule. These compounds have identical physical properties. Chiral column chromatography system is primarily used for the separation and purification …
- キラルクロマトグラフィーの世界市場（～2026年） Chiral chromatography is a technique used for the separation of stereoisomer. The stereoisomer is an isomeric molecule that has identical molecular formula and sequence of bonded atoms. They are differing only in the 3D orientations of their atoms in space. In recent time, increasing number of biote…
- クロマトグラフィーソフトウェアの世界市場（～2026年） Chromatography Data System (CDS) is a software platform that automates various processes such as data filtering, instrumentation control, database management, and data processing. Gas, liquid, ion, and superficial fluid chromatography are some of the types of chromatography. Agilent Technologies, Wa…